1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > 2015 Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.

Market Segmentation Analysis

- Review of the ER, OR and ICU market segments, including their dynamics, trends,
structure, size, growth and major suppliers.

- Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology,
hematology and coagulation procedures by market segment:

- Emergency Rooms;
- Operating/Recovery Suites
- ICUs/CCUs
and test category:

- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Hematology
- Flow Cytometry
- Coagulation
- Immunoproteins
- Drugs of Abuse
- TDM
- Endocrine Function
- Tumor Markers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

Analysis of over 130 diagnostic procedures.

- Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers,
both currently marketed and those in development, including their operating characteristics,
features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales,
product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next ten years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group's proprietary data files.

Contains 973 pages and 153 tables.

Table Of Contents

2015 Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market
Table of Contents


Introduction
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide Market and Technology Overview
Major Routine Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cholesterol
12. Cholinesterase
13. Creatinine
14. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. Ferritin
16. Follate/Folic Acid
17. Fructosamine
18. Gamma-Glutamyl Transpeptidase (GGT)
19. Glucose
20. High Density Lipoprotein (HDL)
21. Iron
22. Lactate Dehydrogenase (LDH)
23. Magnesium
24. Phosphorus
25. Protein
26. Triglycerides
27. Troponin
28. Uric Acid
29. Urinalysis
30. Vitamin B12
Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
a. Hepatitis A
b. Hepatitis B
c. Hepatitis C
d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis
Tumor Markers
1. Alpha-Fetoprotein (AFP)
2. Carcinoembrionic Antigen (CEA)
3. Occult Blood
4. Prostatic Acid Phosphatase (PAP)
5. Prostate-Specific Antigen (PSA)
Major Routine and Special Hematology Tests
1. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
Endocrine Function Tests
1. Cortisol
2. Follicle-Stimulating Hormone (FSH)
3. Gastrin
4. Human Chorionic Gonadotropin (HCG)
5. LH
6. Prolactin
7. T3
8. T3 Uptake
9. Free T3
10. Thyroxine (T4)
11. Free T4
12. TBG
13. TSH
Therapeutic Drug Monitoring (TDM)
1. Overview
2. Carbamazepine
3. Digoxin
4. Gentamicin
5. Lidocaine
6. Lithium
7. Phenytoin/Dilantin
8. Procainamide
9. Quinidine
10. Theophylline
11. Valproic Acid
Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time
Immunoprotein Tests
1. CRP
2. Immunoglobulins
Drugs of Abuse
1. Overview
2. Test Methodologies
3. Amphetamines
4. Barbiturates
5. Benzodiazepines
6. Cannabinoids/Marijuana
7. Cocaine
8. Lysergic Acid Diethylamide (LSD)
9. Methadone
10. Methaqualone
11. Opiates
12. Phencyclidine
Instrumentation
1. Chemistry Analyzers Manufactured by:
- Abaxis
- Abbott
- Alfa Wassermann
- Awareness Technologies
- Beckman Coulter/Danaher
- bioMeriuex
- Carolina Chemistries
- Horiba
- Inverness
- Medica
- Nova Biomedical
- Ortho-Clinical Diagnostics
- Polimedco
- Randox
- Roche
2. Hematology Analyzers Manufactured by:
- Abbott
- Becton Dickinson
- Beckman Coulter/Danaher
- Biocode
- Drew-Scientific
- Diesse Ves Matic
- Horiba
- Menarini
- Nihon Kohden
- Polymedco
- Sysmex
3. Coagulation Analyzers Manufactured by:
- Behnk Elektronik
- Bio/Data
- Cardiovascular Diagnostics
- Diagnostica Stago
- Helena Laboratories
- Instrumentation Laboratory
- ITC Hemochron
- Roche
- Siemens
- Sysmex
- Teco Medical Instruments
- Trinity Biotech
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° Dot Immunobinding Assays
° Capillary Immunoassays
° Particle-Membrane Capture Immunoassay
° Enzyme Amplification
c. Fluorescent Immunoassays
° Fluorescent Polarization
° Time-Resolved Pulse Fluorescence
d. Luminescence
° Chemiluminescence
° Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
° Polymerase Chain Reaction
° Ligase Chain Reaction
° Branched DNA
° Q-Beta Replicase
° Strand Displacement Activation
° Self-Sustained Sequence Replicase
Worldwide Business Environment
U.S.A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
° PPO
° HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
° More Chronic Illness
° Disease Incidence
° Susceptibility to latrogenesis
° Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
Major Suppliers' Instrument Placements,
Installed Base, Consumable Sales and Market Shares
Major Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market SegmentationPotential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
- Abbott
- ADI/America Diagnostica
- Agilent Technologies
- Axis-Shield
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio/Data
- Biomerieux
- Bio-Rad
- Biosite/Inverness/Alere
- Cepheid
- Chrono-Log
- Corgenix
- Decode
- Diadexus
- Diagnocure
- Diagnostica Stago/Trinity Biotech
- Diamedix
- Diasorin
- Eiken Chemical
- EKF Diagnostics
- Fujirebio/Innogenetics
- Helena Laboratories
- Hologic/Gen-Probe
- Horiba
- Instrumentation Laboratory
- International Technidyne/Nexus DX
- Kreatech
- Kyowa Medex
- Life Technologies
- Lonza
- Mackay Life Sciences
- Matritech
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Polartechnics
- Polymedco
- Qiagen
- Roche
- SDIX
- Sequenom
- Siemens
- Sienco
- Sysmex
- Takara Bio
- ThermoFisher
- Tosoh
- Wako
- Zycare/Alere


List of Tables


Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Adenovirus Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing
Candida Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
EBV Tests
Major Companies Developing or Marketing
Gonorrhea Tests
Major Companies Developing or Marketing
Helicobacter Pylori Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
Herpes Tests
Major Companies Developing or Marketing
Influenza Tests
Major Companies Developing or Marketing
Legionella Tests
Major Companies Developing or Marketing
Lyme Disease Tests
Major Companies Developing or Marketing
Measles Tests
Major Companies Developing or Marketing
Meningitis Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing
Mumps Tests
Major Companies Developing or Marketing
Mycoplasma Tests
Major Companies Developing or Marketing
Pneumonia Tests
Major Companies Developing or Marketing
RSV Tests
Major Companies Developing or Marketing
Rotavirus Tests
Major Companies Developing or Marketing
Rubella Tests
Major Companies Developing or Marketing
Salmonella Tests
Major Companies Developing or Marketing
Shigella Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing
Syphilis Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
Prostatic Acid Phosphatase Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
FSH Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
LH Tests
Major Companies Developing or Marketing
Prolactin Tests
Major Companies Developing or Marketing
T3 Tests
Major Companies Developing or Marketing
T4 Tests
Major Companies Developing or Marketing
TSH Tests
Major Companies Developing or Marketing
TDM Tests
Major Companies Developing or Marketing
Digoxin Tests
Major Companies Developing or Marketing
Lithium Tests
Major Companies Developing or Marketing
Phenytoin/Dilantin Tests
Major Companies Developing or Marketing
Theophylline Tests
Major Companies Developing or Marketing
Valproic Acid Tests
Major Companies Developing or Marketing
APTT Tests
Major Companies Developing or Marketing
Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing
Altithrombin III Tests
Major Companies Developing or Marketing
Bleeding Time Tests
Major Companies Developing or Marketing
D-Dimer Tests
Major Companies Developing or Marketing
Factor Assays Tests
Major Companies Developing or Marketing
Fibrin Degradation Product Tests
Major Companies Developing or Marketing
Fibrinogen Tests
Major Companies Developing or Marketing
Heparin Tests
Major Companies Developing or Marketing
Protein C Tests
Major Companies Developing or Marketing
Protein S Tests
Major Companies Developing or Marketing
PT Tests
Major Companies Developing or Marketing
Thrombin Time Tests
Major Companies Developing or Marketing
CRP Tests
Major Companies Developing or Marketing
Drugs of Abuse Tests
Ancillary Hospital Locations Estimated Number
Ancillary Hospital Locations
Annual Utilization
Hospital Emergency Departments
Total Diagnostics Sales Forecast By Market Segment
Hospital Emergency DepartmentsReagent Sales Forecast by Market Segment
Hospital Emergency Departments
Instrument Sales Forecast by Market Segment
Hospital Emergency Departments Routine
and Special Chemistry Test Volume Forecast
Hospital Emergency Departments
Profiles Panels and Individual Tests
Hospital Emergency Departments
Drugs of Abuse Test Volume Forecast
Hospital Emergency Departments
Routine Hematology Test Volume Forecast
Hospital Emergency Departments
Coagulation Test Volume Forecast
Hospital Emergency Departments
Selected Infectious Disease
Test Volume Forecast
Hospital Emergency Departments
Routine and Special Chemistry Reagent
Market Forecast by Test
Hospital Emergency Departments
Drugs of Abuse Reagent Market Forecast By Test
Hospital Emergency Departments
Hematology Reagent Market Forecast
Hospital Emergency Departments
Coagulation Reagent Market Forecast
Hospital Emergency Departments
Selected Infectious Disease Reagent MarketForecast by Test
Hospital Operating and Recovery Suites
Total Diagnostics Sales Forecast by Market Segment
Hospital Operating and Recovery SuitesReagent Sales Forecast by Market Segment
Hospital Operating and Recovery Suites
Instrument Sales Forecast By Market Segment
Hospital Operating and Recovery Suites
Routine and Special Chemistry Reagent
Test Volume Forecast
Hospital Operating and Recovery Suites
Routine Hematology Test Volume Forecast
Hospital Operating and Recovery Suites
Coagulation Test Volume Forecast
Hospital Operating and Recovery Suites
Routine and Special Chemistry Reagent Market
Forecast by Test
Hospital Operating and Recovery Suites
Hematology Reagent Market Forecast
Hospital Operating and Recovery Suites
Coagulation Reagent Market Forecast
Hospital ICUs/CCUs Total Diagnostics
Sales Forecast by Market Segment
Hospital ICUs/CCUsReagent Sales Forecast by Market Segment
ICUs/CCUs
Instrument Sales Forecast by Market Segment
Hospital ICUs/CCUs Routine
and Special Chemistry Test Volume Forecast
Hospital ICUs/CCUs Routine
Hematology Test Volume Forecast
Hospital ICUs/CCUs
Coagulation Test Volume Forecast
Hospital ICUs/CCUs Routine
and Special Chemistry Reagent MarketForecast by Test
Hospital ICUs/CCUs
Hematology Reagent Market Forecast
Hospital ICUs/CCUs
Coagulation Reagent Market Forecast
Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales
and Market Shares
Major Suppliers of Clinical Chemistry
Reagents, Estimated Sales and Market Shares
Major Suppliers of Clinical Chemistry
Analyzers, Estimated Sales and Market Shares
Major Suppliers of Immunodiagnostic
Products, Estimated Sales and Market Shares
Major Suppliers of Immunoassay
Reagents, Estimated Sales and Market Shares
Major Suppliers of Immunoassay
Analyzers, Estimated Sales and Market Shares
AIDS Testing MarketEstimated Market Shares of Major Suppliers
Chlamydia Testing MarketEstimated Market Shares of Major Suppliers
CMV Testing MarketEstimated Market Shares of Major Suppliers
Gonorrhea Testing MarketEstimated Market Shares of Major Suppliers
Helicobacter Pylori Testing MarketEstimated Market Shares of Major Suppliers
Hepatitis Testing MarketEstimated Market Shares of Major Suppliers
Herpes Testing MarketEstimated Market Shares of Major Suppliers
Influenza Testing MarketEstimated Market Shares of Major Suppliers
Lyme Disease Testing MarketEstimated Market Shares of Major Suppliers
Mononucleosis Testing MarketEstimated Market Shares of Major Suppliers
Rubella Testing MarketEstimated Market Shares of Major Suppliers
Streptococci Testing MarketEstimated Market Shares of Major Suppliers
Syphilis Testing MarketEstimated Market Shares of Major Suppliers
AFP Testing Market by Major Supplier
CA 15-3/27-29 Testing Market by Major Supplier
CA 19-9 Testing Market by Major Supplier
CEA Testing Market by Major Supplier
PAP Testing Market by Major Supplier
PSA Testing Market by Major Supplier
Hematology AnalyzersEstimated Placements and Installed Base
Flow CytometersEstimated Placements and Installed Base
Hematology Diagnostics MarketEstimated Market Shares of Major Suppliers
Hematology Instrument MarketEstimated Market Shares of Major Suppliers
Hematology Consumable MarketEstimated Market Shares of Major Suppliers
Flow Cytometry Diagnostics MarketEstimated Market Shares of Major Suppliers
Flow Cytometry Consumable MarketEstimated Market Shares of Major Suppliers
Flow Cytometry Instrument MarketEstimated Market Shares of Major Suppliers
Major Suppliers of Coagulation Diagnostic Products, Estimated Market Shares
of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.